YMAB
Y-mAbs Therapeutics
YMAB
YMAB
Delisted
YMAB was delisted on the 15th of September, 2025.
45 hedge funds and large institutions have $222M invested in Y-mAbs Therapeutics in 2019 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 13 increasing their positions, 14 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0.6% less ownership
Funds ownership: 25.41% → 24.8% (-0.6%)
7% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 14
Holders
45
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$13.6M | |
| 2 | +$6.57M | |
| 3 | +$2.82M | |
| 4 |
BlackRock
New York
|
+$716K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$715K |
Top Sellers
| 1 | -$17.5M | |
| 2 | -$6.3M | |
| 3 | -$2.66M | |
| 4 |
AG
Artal Group
Luxembourg
|
-$1.02M |
| 5 |
MWNA
Marshall Wace North America
New York
|
-$994K |